Paladin Wealth LLC Invests $39,000 in HealthEquity, Inc. (NASDAQ:HQY)

Paladin Wealth LLC acquired a new position in HealthEquity, Inc. (NASDAQ:HQY) in the 3rd quarter, Holdings Channel reports. The institutional investor acquired 473 shares of the company’s stock, valued at approximately $39,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Exchange Traded Concepts LLC lifted its position in shares of HealthEquity by 17.3% during the 3rd quarter. Exchange Traded Concepts LLC now owns 9,568 shares of the company’s stock worth $783,000 after buying an additional 1,414 shares during the last quarter. Inspire Investing LLC grew its stake in HealthEquity by 75.2% during the third quarter. Inspire Investing LLC now owns 24,027 shares of the company’s stock worth $1,967,000 after purchasing an additional 10,312 shares during the period. Atomi Financial Group Inc. acquired a new stake in HealthEquity in the third quarter valued at approximately $208,000. GAMMA Investing LLC grew its stake in HealthEquity by 57.8% in the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after acquiring an additional 344 shares during the period. Finally, Handelsbanken Fonder AB boosted its position in shares of HealthEquity by 19.7% during the third quarter. Handelsbanken Fonder AB now owns 20,616 shares of the company’s stock valued at $1,687,000 after buying an additional 3,400 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on HQY. Bank of America dropped their price target on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and set a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Barrington Research reissued an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. Finally, Wells Fargo & Company upped their price target on HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research report on Thursday, June 20th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, HealthEquity currently has an average rating of “Buy” and a consensus price target of $103.83.

Insider Buying and Selling at HealthEquity

In related news, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of the business’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the transaction, the insider now directly owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 44,497 shares of company stock valued at $3,579,769. Company insiders own 2.20% of the company’s stock.

HealthEquity Price Performance

Shares of HQY stock opened at $84.97 on Tuesday. The stock’s 50-day moving average is $77.48 and its 200 day moving average is $79.31. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity, Inc. has a 1-year low of $61.81 and a 1-year high of $88.26. The company has a market cap of $7.39 billion, a P/E ratio of 92.36, a PEG ratio of 1.31 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. Research analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.